VX15/2503 in Combination With Avelumab in Advanced Non-small Cell Lung Cancer
Clinical trial NCT03268057 · COMPLETED
Trial details
- NCT number
- NCT03268057
- Sponsor
- Vaccinex Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-05
- Primary completion
- 2020-09-09
- Enrollment
- 62
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.